Received Sep 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | EY57A | IM / RA |
Patient was to receive Hep B injection. Patient was given Hep A injection. To date the patient has had no adverse reactions.
N/A